Dyne Therapeutics, INC. 8-K Filing
Ticker: DYN · Form: 8-K · Filed: Dec 8, 2025 · CIK: 1818794
| Field | Detail |
|---|---|
| Company | Dyne Therapeutics, INC. (DYN) |
| Form Type | 8-K |
| Filed Date | Dec 8, 2025 |
| Pages | 7 |
| Reading Time | 8 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Dyne Therapeutics, INC. (ticker: DYN) to the SEC on Dec 8, 2025.
What are the key financial figures in this filing?
Key dollar amounts include: $0.0001 (ange on which registered Common stock, $0.0001 par value per share DYN Nasdaq Glob).
How long is this filing?
Dyne Therapeutics, INC.'s 8-K filing is 7 pages with approximately 2,105 words. Estimated reading time is 8 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 2,105 words · 8 min read · ~7 pages · Grade level 13.8 · Accepted 2025-12-08 06:36:58
Key Financial Figures
- $0.0001 — ange on which registered Common stock, $0.0001 par value per share DYN Nasdaq Glob
Filing Documents
- d16518d8k.htm (8-K) — 50KB
- d16518dex991.htm (EX-99.1) — 45KB
- d16518dex992.htm (EX-99.2) — 45KB
- g16518ex99_2p10g1.jpg (GRAPHIC) — 389KB
- g16518ex99_2p11g1.jpg (GRAPHIC) — 486KB
- g16518ex99_2p12g1.jpg (GRAPHIC) — 476KB
- g16518ex99_2p13g1.jpg (GRAPHIC) — 216KB
- g16518ex99_2p14g1.jpg (GRAPHIC) — 266KB
- g16518ex99_2p15g1.jpg (GRAPHIC) — 249KB
- g16518ex99_2p16g1.jpg (GRAPHIC) — 290KB
- g16518ex99_2p17g1.jpg (GRAPHIC) — 357KB
- g16518ex99_2p18g1.jpg (GRAPHIC) — 208KB
- g16518ex99_2p19g1.jpg (GRAPHIC) — 212KB
- g16518ex99_2p1g1.jpg (GRAPHIC) — 514KB
- g16518ex99_2p20g1.jpg (GRAPHIC) — 198KB
- g16518ex99_2p21g1.jpg (GRAPHIC) — 174KB
- g16518ex99_2p22g1.jpg (GRAPHIC) — 195KB
- g16518ex99_2p23g1.jpg (GRAPHIC) — 154KB
- g16518ex99_2p24g1.jpg (GRAPHIC) — 336KB
- g16518ex99_2p25g1.jpg (GRAPHIC) — 200KB
- g16518ex99_2p26g1.jpg (GRAPHIC) — 324KB
- g16518ex99_2p27g1.jpg (GRAPHIC) — 199KB
- g16518ex99_2p28g1.jpg (GRAPHIC) — 289KB
- g16518ex99_2p29g1.jpg (GRAPHIC) — 253KB
- g16518ex99_2p2g1.jpg (GRAPHIC) — 790KB
- g16518ex99_2p30g1.jpg (GRAPHIC) — 183KB
- g16518ex99_2p31g1.jpg (GRAPHIC) — 360KB
- g16518ex99_2p32g1.jpg (GRAPHIC) — 440KB
- g16518ex99_2p33g1.jpg (GRAPHIC) — 265KB
- g16518ex99_2p34g1.jpg (GRAPHIC) — 461KB
- g16518ex99_2p3g1.jpg (GRAPHIC) — 182KB
- g16518ex99_2p4g1.jpg (GRAPHIC) — 440KB
- g16518ex99_2p5g1.jpg (GRAPHIC) — 183KB
- g16518ex99_2p6g1.jpg (GRAPHIC) — 205KB
- g16518ex99_2p7g1.jpg (GRAPHIC) — 462KB
- g16518ex99_2p8g1.jpg (GRAPHIC) — 274KB
- g16518ex99_2p9g1.jpg (GRAPHIC) — 205KB
- g16518g1207204801311.jpg (GRAPHIC) — 3KB
- 0001193125-25-310516.txt ( ) — 14662KB
- dyn-20251208.xsd (EX-101.SCH) — 3KB
- dyn-20251208_lab.xml (EX-101.LAB) — 17KB
- dyn-20251208_pre.xml (EX-101.PRE) — 11KB
- d16518d8k_htm.xml (XML) — 3KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release, dated December 8, 2025. 99.2 Presentation, dated December 8, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. DYNE THERAPEUTICS, INC. Date: December 8, 2025 By: /s/ John G. Cox Name: John G. Cox Title: President and Chief Executive Officer